Amarin

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amarin ( AMRN) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. This stock is trading up 10.1% at $8.83 in recent trading.

Today's Range: $7.77-$9

52-Week Range: $5.99-$19.87

Volume: 7.7 million

Three-Month Average Volume: 3.05 million

>>Health Care Stocks Bought and Sold by Hedge Funds

From a technical perspective, AMRN is spiking big today and moving back above its 50-day moving average of $8.11 with monster volume. This move puts AMRN within range of triggering some near-term breakouts. Those breakouts will hit once $9.11 to $9.50 are taken out with volume.

A sustained high-volume move and close above those levels will signal that this stock wants to trend higher. Look for volume on that move that's near or well above 3,053,130 shares. If we get that action soon, look for AMRN to challenge the mid-$11s.

If you liked this article you might like

Biotech Premarket Movers: Cempra, Novavax, Ionis

Amarin (AMRN) Stock Drops After Pricing Public Offering

Tetraphase Executive Profits Hours Before Stock Plummets

5 Stocks Ready for Breakouts -- Must-See Charts

3 Stocks Under $10 Making Big Moves